Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle
- PMID: 15913551
- DOI: 10.1016/j.bbrc.2005.05.035
Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle
Abstract
Triglyceride accumulation in skeletal muscle contributes to insulin resistance in obesity. We recently showed that alpha-lipoic acid (ALA) reduces body weight and prevents the development of diabetes in diabetes-prone obese rats by reducing triglyceride accumulation in non-adipose tissues. AMP-activated protein kinase (AMPK) is a major regulator of cellular energy metabolism. We examined whether ALA lowers triglyceride accumulation in skeletal muscle by activating AMPK. Alpha2-AMPK activity was decreased in obese rats compared to control rats. Administration of ALA to obese rats increased insulin-stimulated glucose disposal in whole body and in skeletal muscle. ALA also increased fatty acid oxidation and activated AMPK in skeletal muscle. Adenovirus-mediated administration of dominant negative AMPK into skeletal muscle prevented the ALA-induced increases in fatty acid oxidation and insulin-stimulated glucose uptake. These results suggest that ALA-induced improvement of insulin sensitivity is mediated by activation of AMPK and reduced triglyceride accumulation in skeletal muscle.
Similar articles
-
Alpha-lipoic acid increases cardiac glucose oxidation independent of AMP-activated protein kinase in isolated working rat hearts.Basic Res Cardiol. 2007 Sep;102(5):436-44. doi: 10.1007/s00395-007-0661-4. Epub 2007 May 29. Basic Res Cardiol. 2007. PMID: 17530314
-
Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats.Am J Physiol Endocrinol Metab. 2003 May;284(5):E923-30. doi: 10.1152/ajpendo.00360.2002. Epub 2002 Dec 3. Am J Physiol Endocrinol Metab. 2003. PMID: 12464581
-
Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.Diabetes. 2006 Aug;55(8):2277-85. doi: 10.2337/db06-0062. Diabetes. 2006. PMID: 16873691
-
Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes.Curr Drug Targets Immune Endocr Metabol Disord. 2002 Jul;2(2):119-27. Curr Drug Targets Immune Endocr Metabol Disord. 2002. PMID: 12476786 Review.
-
AMP-activated protein kinase and the regulation of glucose transport.Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E867-77. doi: 10.1152/ajpendo.00207.2006. Epub 2006 Jul 5. Am J Physiol Endocrinol Metab. 2006. PMID: 16822958 Review.
Cited by
-
Effects of lipoic acid on apelin in 3T3-L1 adipocytes and in high-fat fed rats.J Physiol Biochem. 2011 Sep;67(3):479-86. doi: 10.1007/s13105-011-0087-1. Epub 2011 Apr 2. J Physiol Biochem. 2011. PMID: 21461750
-
Targeting Mitochondrial Dysfunction for the Treatment of Diabetic Complications: Pharmacological Interventions through Natural Products.Pharmacogn Rev. 2017 Jul-Dec;11(22):128-135. doi: 10.4103/phrev.phrev_41_16. Pharmacogn Rev. 2017. PMID: 28989247 Free PMC article. Review.
-
Irisin, a Novel Myokine, Regulates Glucose Uptake in Skeletal Muscle Cells via AMPK.Mol Endocrinol. 2015 Jun;29(6):873-81. doi: 10.1210/me.2014-1353. Epub 2015 Mar 31. Mol Endocrinol. 2015. PMID: 25826445 Free PMC article.
-
Targeting hepatic sulfane sulfur/hydrogen sulfide signaling pathway with α-lipoic acid to prevent diabetes-induced liver injury via upregulating hepatic CSE/3-MST expression.Diabetol Metab Syndr. 2022 Oct 13;14(1):148. doi: 10.1186/s13098-022-00921-x. Diabetol Metab Syndr. 2022. PMID: 36229864 Free PMC article.
-
Nutritional Modulation of AMPK-Impact upon Metabolic-Inflammation.Int J Mol Sci. 2018 Oct 9;19(10):3092. doi: 10.3390/ijms19103092. Int J Mol Sci. 2018. PMID: 30304866 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources